Bridging Chemotherapy: Follicular Lymphoma, Mantle Cell Lymphoma, and CLL

Link:
Autor/in:
Beteiligte Personen:
  • Kröger, Nicolaus
  • Gribben, John
  • Chabannon, Christian
  • Yakoub-Agha, Ibrahim
  • Einsele, Hermann
Verlag/Körperschaft:
Springer International Publishing
Erscheinungsjahr:
2022
Medientyp:
Text
Beschreibung:
  • While lisocabtagene maraleucel (liso-cel) is the only product that is specifically approved to treat grade 3B follicular lymphoma (FL), specifically in aggressive lymphoma indications, to date, axi-cel is the first and only approved CAR-T product for indolent NHL.
  • While lisocabtagene maraleucel (liso-cel) is the only product that is specifically approved to treat grade 3B follicular lymphoma (FL), specifically in aggressive lymphoma indications, to date, axi-cel is the first and only approved CAR-T product for indolent NHL.
Lizenz:
  • info:eu-repo/semantics/openAccess
Quellsystem:
Forschungsinformationssystem des UKE
Interne Metadaten
Quelldatensatz
oai:pure.atira.dk:publications/29993917-96b0-4f4a-b890-cae70c6c8fe2